Donaldson Capital Management LLC raised its holdings in shares of The Allstate Co. (NYSE:ALL - Free Report) by 1.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 317,985 shares of the insurance provider's stock after purchasing an additional 4,805 shares during the period. Allstate accounts for approximately 2.5% of Donaldson Capital Management LLC's investment portfolio, making the stock its 14th biggest holding. Donaldson Capital Management LLC owned about 0.12% of Allstate worth $65,845,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Brighton Jones LLC boosted its holdings in Allstate by 60.2% in the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider's stock worth $1,253,000 after acquiring an additional 2,443 shares in the last quarter. Revolve Wealth Partners LLC acquired a new stake in Allstate in the 4th quarter worth approximately $231,000. Stenger Family Office LLC acquired a new stake in Allstate in the 4th quarter worth approximately $439,000. Golden State Wealth Management LLC purchased a new stake in Allstate during the 4th quarter worth approximately $57,000. Finally, Quotient Wealth Partners LLC increased its stake in Allstate by 8.4% during the 4th quarter. Quotient Wealth Partners LLC now owns 1,149 shares of the insurance provider's stock valued at $222,000 after purchasing an additional 89 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company's stock.
Allstate Price Performance
Shares of Allstate stock traded up $3.00 on Thursday, reaching $199.18. The company's stock had a trading volume of 380,132 shares, compared to its average volume of 1,612,107. The Allstate Co. has a 52-week low of $156.66 and a 52-week high of $213.18. The company has a market capitalization of $52.75 billion, a P/E ratio of 11.72, a PEG ratio of 1.01 and a beta of 0.35. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The stock has a 50-day moving average price of $199.50 and a 200-day moving average price of $197.09.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 EPS for the quarter, missing the consensus estimate of $3.98 by ($0.45). The company had revenue of $14.30 billion during the quarter, compared to analysts' expectations of $16.41 billion. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Allstate's revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.13 EPS. Analysts expect that The Allstate Co. will post 18.74 EPS for the current year.
Allstate announced that its board has approved a stock buyback program on Wednesday, February 26th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the insurance provider to repurchase up to 3% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its shares are undervalued.
Allstate Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 9th will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $4.00 annualized dividend and a dividend yield of 2.01%. Allstate's dividend payout ratio (DPR) is presently 27.32%.
Wall Street Analyst Weigh In
ALL has been the subject of several research reports. Argus upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. Raymond James reaffirmed a "strong-buy" rating and set a $250.00 price target (up previously from $240.00) on shares of Allstate in a research report on Monday, May 5th. Barclays dropped their price target on Allstate from $183.00 to $172.00 and set an "underweight" rating on the stock in a research note on Friday, April 11th. William Blair started coverage on Allstate in a research note on Friday, June 6th. They issued a "sector outperform" rating for the company. Finally, Wall Street Zen raised Allstate from a "hold" rating to a "buy" rating in a report on Thursday, May 1st. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $225.20.
Read Our Latest Report on ALL
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.